Valeant Pharmaceuticals International (VRX)

SUMMARY

BULLS

BEARS

DATA CENTRAL

Day
52 Wk

Valeant Pharmaceuticals Closed A Second Consecutive New 52-Week High Thursday

RTTNews Jun 26

Valeant Pharmaceuticals (VRX) traded to the upside for the majority of Thursday morning, but moved in a narrow range throughout the afternoon. The stock finished the session higher by $1.58 at $26.18 on above average volume.

Valeant Pharmaceuticals Closed At New High For Year Wednesday

RTTNews Jun 25

Valeant Pharmaceuticals (VRX) spiked to the upside around 10:00AM Wednesday, but settled into a range for the majority of the session. Shares finished higher by $0.73 at $24.60 on above average volume.

Valueact Buys $3M Worth of Valeant Pharma

TheStreet.com Jun 24

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Insider Buys $4.8M Worth of Valeant

TheStreet.com Jun 10

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Penwest Pharma (PPCO, Endo Pharma (ENDP) Grant Valeant (VRX) Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand

StreetInsider.com Jun 9

Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Penwest+Pharma+%28PPCO%2C+Endo+Pharma+%28ENDP%29+Grant+Valeant+%28VRX%29+Exclusive+License+to+Market+Opana%28r%29+ER+in+Canada%2C+Australia+and+New+Zealand/4717398.html for the...

Insider Buys $7M Worth of Valeant Pharma

TheStreet.com Jun 5

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Valeant, Schering-Plough in deal for hepatitis C drug

Reuters Jun 1

Valeant Pharmaceuticals International said it entered into an exclusive option agreement with

Valeant Pharmaceuticals (VRX) Reports Encouraging Final Results With Taribavirin Phase IIb Study

StreetInsider.com Jun 1

Visit StreetInsider.com at http://www.streetinsider.com/FDA/Valeant+Pharmaceuticals+%28VRX%29+Reports+Encouraging+Final+Results+With+Taribavirin+Phase+IIb+Study/4695424.html for the full story.

Valeant (VRX) Announces $300 Million Increase to Securities Repurchase Program

StreetInsider.com May 28

Visit StreetInsider.com at http://www.streetinsider.com/Stock+Buybacks/Valeant+%28VRX%29+Announces+%24300+Million+Increase+to+Securities+Repurchase+Program/4688089.html for the full story.

Valueact Buys $1.1M Worth Valeant Pharma

TheStreet.com May 20

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Suggest other news sources for this topic


	Suggest a News Source Topic Top news source/blog that we're missing Why do you recommend this news source? Close Thanks for your suggestion!

The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.

[edit] References

Retrieved from "http://www.wikinvest.com/stock/Valeant_Pharmaceuticals_International_(VRX)"

Categories: Pharma & Healthcare | Drug Manufacturers - Other

Worried about pump and dump?

We review changes
for stock spam

» read more

Want to make Wikinvest better?

We need your help,
contribute today

» learn how

Do you write software?

We are recruiting
the best engineers

» view jobs

Like Wikinvest?

Spread the word —
Tell your friends!

» spread the word

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.